BPC-157, TB-500, and GHK-CU Research Compound Set

Glow Blend 70 mg is a multi‑peptide research formulation presented as a lyophilised vial for controlled analytical and in‑vitro experimentation. It contains three established research peptides — BPC‑157, TB‑500, and GHK‑Cu — enabling researchers to study combined peptide activity, cross‑pathway interactions, and structural or signalling behaviour within multi‑compound experimental systems. Each production batch undergoes internal purity verification to ensure suitability for regulated laboratory environments. The formulation brings together peptides with distinct mechanistic profiles: BPC‑157 for peptide‑mediated signalling studies, TB‑500 for actin‑related and cytoskeletal research, and GHK‑Cu for copper‑dependent biochemical and regulatory pathway investigation. When used in combination, these compounds support exploration of convergent signalling responses, matrix‑associated processes, and peptide–metal interactions under controlled laboratory conditions.